Aurinia Pharmaceuticals Inc (AUPH) vs Vericel Corporation (VCEL)
- Aurinia Pharmaceuticals Inc AUPH 16.51 −1.32%
- Vericel Corporation VCEL 40.13 −2.17%
Aurinia Pharmaceuticals Inc and Vericel Corporation are both Biotechnology companies. Aurinia Pharmaceuticals Inc and Vericel Corporation are of similar size ($2.2B and $2.1B). Aurinia Pharmaceuticals Inc trades at the lower P/E: 6.9× against 83.6×. Vericel Corporation grew revenue faster over the last twelve months: 23.0% against 19.8%. Aurinia Pharmaceuticals Inc has the higher net margin (100.8% vs 7.91%) and the higher return on invested capital (40.8% vs 5.49%). Across the 22 metrics below, Aurinia Pharmaceuticals Inc leads on 17 and Vericel Corporation on 5.
Valuation
Profitability
| Metric | AUPH | VCEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 90.36% | 74.56% | 65.16% |
| Operating margin | 45.15% | 5.95% | 0.00% |
| Net margin | 100.84% | 7.91% | 0.00% |
| Free cash flow margin | 56.20% | 20.13% | 0.00% |
| Return on equity | 66.12% | 7.16% | (56.36%) |
| Return on assets | 48.52% | 5.16% | (48.04%) |
| Return on invested capital | 40.76% | 5.49% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack